Next Article in Journal
Chemopreventive Effects of Sarcotriol on Ultraviolet B-induced Skin Tumor Development in SKH-1 Hairless Mice
Next Article in Special Issue
Evaluation of Harmful Algal Bloom Outreach Activities
Previous Article in Journal / Special Issue
Report on the First Detection of Pectenotoxin-2, Spirolide-A and Their Derivatives in French Shellfish
Article Menu

Export Article

Correction published on 29 June 2010, see Mar. Drugs 2010, 8(7), 2013.

Open AccessArticle
Mar. Drugs 2007, 5(4), 180-196;

Production of the Neurotoxin BMAA by a Marine Cyanobacterium

Institute for Ethnomedicine, Box 3464, Jackson Hole, Wyoming 83001, USA
Department of Biological Science, California State University, Fullerton, California 92834, USA
Author to whom correspondence should be addressed.
Received: 17 November 2007 / Accepted: 4 December 2007 / Published: 6 December 2007
(This article belongs to the Special Issue Marine Toxins)
Full-Text   |   PDF [1837 KB, uploaded 24 February 2015]   |  


Diverse species of cyanobacteria have recently been discovered to produce theneurotoxic non-protein amino acid β-methylamino-L-alanine (BMAA). In Guam, BMAAhas been studied as a possible environmental toxin in the diets of indigenous Chamorropeople known to have high levels of Amyotrophic Lateral Sclerosis/ ParkinsonismDementia Complex (ALS/PDC). BMAA has been found to accumulate in brain tissues ofpatients with progressive neurodegenerative illness in North America. In Guam, BMAAwas found to be produced by endosymbiotic cyanobacteria of the genus Nostoc which livein specialized cycad roots. We here report detection of BMAA in laboratory cultures of afree-living marine species of Nostoc. We successfully detected BMAA in this marinespecies of Nostoc with five different methods: HPLC-FD, UPLC-UV, Amino AcidAnalyzer, LC/MS, and Triple Quadrupole LC/MS/MS. This consensus of five differentanalytical methods unequivocally demonstrates the presence of BMAA in this marinecyanobacterium. Since protein-associated BMAA can accumulate in increasing levelswithin food chains, it is possible that biomagnification of BMAA could occur in marineecosystems similar to the biomagnification of BMAA in terrestrial ecosystems. Productionof BMAA by marine cyanobacteria may represent another route of human exposure toBMAA. Since BMAA at low concentrations causes the death of motor neurons, low levelsof BMAA exposure may trigger motor neuron disease in genetically vulnerableindividuals. View Full-Text
Keywords: Nostoc; motor neuron disease; ALS/PDC; LC/MS/MS; biomagnification Nostoc; motor neuron disease; ALS/PDC; LC/MS/MS; biomagnification

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Banack, S.A.; Johnson, H.E.; Cheng, R.; Cox, P.A. Production of the Neurotoxin BMAA by a Marine Cyanobacterium. Mar. Drugs 2007, 5, 180-196.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top